AP NEWS

Global Cell RNA Detection Market 2018-2022 - ResearchAndMarkets.com

October 9, 2018

DUBLIN--(BUSINESS WIRE)--Oct 9, 2018--The “Global Cell RNA Detection Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The Global Cell RNA Detection Market to grow at a CAGR of 5.76% during the period 2018-2022.

Global Cell RNA Detection Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Growing opportunities in developing nations are one of the major trends in the market. Emerging economies provide huge growth opportunities due to extensive government support and significant R&D investments by the leading vendors.

According to the report, one driver influencing this market is the increased demand for cell RNA detection in biotechnology. Cell RNA detection is generally used for clinical purposes. However, cell RNA detection is gaining traction in the biotechnology sector for various purposes such as cell engineering, protein engineering, and physiological research.

Further, the report states that one challenge affecting this market is the high costs associated with cell-based research. At times, researchers also misidentify cell lines and use contaminated cells for experiments. Such experiments generate incorrect results, which increases the cost associated with the particular study.

Key vendors

Agilent Technologies Merck KGaA Promega QIAGEN Thermo Fisher Scientific

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: MARKET SIZING

Market definition Market sizing 2017 Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

Comparison by end-user Pharmaceutical and biotechnology companies Research and academic institutes Others Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers Market challenges

PART 12: MARKET TRENDS

Growing opportunities in developing nations Presence of innovative products Growing number of workshops/seminars

PART 13: VENDOR LANDSCAPE

Overview Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/4d99k2/global_cell_rna?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181009005975/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/09/2018 12:52 PM/DISC: 10/09/2018 12:52 PM

http://www.businesswire.com/news/home/20181009005975/en

AP RADIO
Update hourly